47 results on '"Laubender, Ruediger P"'
Search Results
2. Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay
3. Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
4. Multicenter evaluation of blood‐based biomarkers for the detection of endometriosis and adenomyosis: A prospective non‐interventional study.
5. MRI evidence for preserved regulation of intracranial pressure in patients with cerebral arteriovenous malformations
6. Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm
7. Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation
8. Hyperdense basilar artery sign—a reliable sign of basilar artery occlusion
9. Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial
10. Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia
11. Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel‐group RCT: A structural model approach
12. Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
13. Performance characteristics of an ECL immunoassay for the quantitation of serum periostin
14. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104
15. Medical Value as a New Strategy to Increase Corporate Viability: Market Chances and Limitations in the Diagnostic Industry
16. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104
17. A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model
18. High-resolution computed tomography-based length assessments of the cochlea – an accuracy evaluation
19. Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation
20. Spirometry reference equations for central European populations from school age to old age
21. Correction: MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury
22. Correction
23. A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model
24. Magnetic Resonance–Based Estimation of Intracranial Pressure Correlates With Ventriculoperitoneal Shunt Valve Opening Pressure Setting in Children With Hydrocephalus
25. MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury
26. Spirometry Reference Equations for Central European Populations from School Age to Old Age
27. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial
28. External Validation of 2 Prognostic Indices for Patients With Advanced Pancreatic Cancer Treated With First-line Therapy
29. Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count
30. Cetuximab-related skin toxicity in metastatic colorectal cancer (mCRC) patients and its correlation with molecular markers: Results from the German AIO CRC 0104 trial.
31. Validating the prognostic relevance of initial change in tumor size using a series of therapeutic regimens for patients with metastatic colorectal cancer (mCRC).
32. Evaluating the agreement between the empirical volumes of tumor lesions and the estimated volumes of tumor lesions based on the longest diameter.
33. Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D mutated metastatic colorectal cancer (mCRC)? A meta-analysis of 54 cases.
34. Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials
35. Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI
36. Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status
37. Altered Cerebrovenous Drainage in Patients With Migraine as Assessed by Phase-Contrast Magnetic Resonance Imaging
38. Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia
39. Anisotropy of Callosal Motor Fibers in Combination With Transcranial Magnetic Stimulation in the Course of Motor Development
40. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial.
41. Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI.
42. Cetuximab-based or bevacizumab-based first-line treatment in patients with KRASp.G13D-mutated metastatic colorectal cancer
43. S1120 Fistulas Are Strongly Associated with Concomitant Intestinal Stenosis in Patients with Crohn's Disease
44. MRI evidence for altered venous drainage and intracranial compliance in mild traumatic brain injury
45. Correction.
46. A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model.
47. Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.